People with #SCD in the #UK will be able to access @Novartis' treatment #Adakveo (#crizanlizumab), thanks to a special arrangement between the drugmaker & @NICEComms.
This makes Adakveo the 1st new treatment for SCD available via the #NHS for 20 years!
https://t.co/EWn7zixRd8